Home > About EXJADE > Overview

EXJADE®-The essentials of removing toxic iron in patients across underlying anemias

About EXJADE

EXJADE removes toxic iron across anemias

EXJADE is the only once-daily oral iron chelator.

EXJADE is indicated for the treatment of chronic iron overload due to frequent blood transfusions (≥ 7 ml/kg/month of packed red blood cells) in patients with beta thalassemia major aged 6 years and older.

EXJADE is also indicated for the treatment of chronic iron overload due to blood transfusions when deferoxamine therapy is contraindicated or inadequate in the following patient groups:

  • in patients with beta thalassemia major with iron overload due to frequent blood transfusions (≥7 ml/kg/month of packed red blood cells) aged 2 to 5 years
  • in patients with beta thalassemia major with iron overload due to infrequent blood transfusions (<7 ml/kg/month of packed red blood cells) aged 2 years and older
  • in patients with other anemias aged 2 years and older

EXJADE is also indicated for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inadequate in patients with non-trans fusion-dependent thalassemia syndromes aged 10 years and older.

EXJADE ALLOWS YOU TO TAILOR DOSING TO MEET INDIVIDUAL TREATMENT GOALS

Find out more about the dosing options of EXJADE.

NEW TO EXJADE?

Learn more with frequently asked questions.